POSA80 Natalizumab Utilization in Terms of Dosing Interval and Costs: A 2015-2019 Population-Based Study
Abstract
Authors
G Affinito L Santoni E Montella S Masera V Brescia Morra M Triassi R Palladino M Moccia
G Affinito L Santoni E Montella S Masera V Brescia Morra M Triassi R Palladino M Moccia
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now